Working… Menu
Trial record 80 of 535 for:    ESCITALOPRAM AND Disorders

Treatment of Pediatric Anxiety Disorders by Predicting Treatment Response Through Biocellular Markers and Sleep

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02189213
Recruitment Status : Active, not recruiting
First Posted : July 14, 2014
Last Update Posted : November 16, 2018
Columbia University
Information provided by (Responsible Party):
Amir A. Levine, New York State Psychiatric Institute

No Study Results Posted on for this Study
Recruitment Status : Active, not recruiting
Estimated Primary Completion Date : September 2019
Estimated Study Completion Date : October 2019